Personalised vaccine marks major cancer breakthrough

A personalised cancer vaccine has been credited with preventing melanoma from returning following surgery.

Stephane Bancel, chief executive of Moderna, was at a Lebanese restaurant celebrating a friend’s birthday late on Aug 13 when he got the call.An mRNA cancer vaccine the company had been developing with Merck had hit its mark – the first success of a therapeutic cancer vaccine in late-stage testing after more than 100 y

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough  Reuters

New research has round the mRNA vaccine could help boost the survival rate of cancer patients.